Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

SHA:688163 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,718	1,900	2,163	2,282	-	-
Market Cap Growth	40.10%	-12.16%	-5.22%	-	-	-
Enterprise Value	1,936	1,053	1,312	1,366	-	-
Last Close Price	25.12	17.29	19.23	19.67	-	-
PE Ratio	59.69	42.91	55.79	35.55	-	-
PS Ratio	13.82	9.75	11.38	13.10	-	-
PB Ratio	2.42	1.74	1.99	2.04	-	-
P/TBV Ratio	2.47	1.77	2.04	2.08	-	-
P/FCF Ratio	-	-	521.89	55.06	-	-
P/OCF Ratio	57.32	37.82	65.92	33.61	-	-
EV/Sales Ratio	9.84	5.40	6.90	7.84	-	-
EV/EBITDA Ratio	27.98	16.08	26.52	21.21	-	-
EV/EBIT Ratio	41.29	22.82	39.49	27.09	-	-
EV/FCF Ratio	-69.35	-	316.44	32.96	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.01	0.04	-
Debt / EBITDA Ratio	0.06	0.06	0.26	0.21	0.15	-
Debt / FCF Ratio	-	-	3.13	0.33	0.22	-
Asset Turnover	0.17	0.17	0.17	0.22	0.58	0.55
Inventory Turnover	1.24	1.04	1.00	0.65	0.74	0.68
Quick Ratio	27.08	44.34	35.90	35.06	11.16	8.42
Current Ratio	28.72	46.70	37.98	37.10	14.05	12.03
Return on Equity (ROE)	4.07%	4.06%	3.51%	8.61%	23.03%	20.01%
Return on Assets (ROA)	2.54%	2.56%	1.81%	4.02%	14.34%	14.53%
Return on Invested Capital (ROIC)	11.95%	16.41%	13.28%	21.61%	36.27%	36.31%
Return on Capital Employed (ROCE)	4.20%	4.20%	3.00%	4.40%	21.30%	26.50%
Earnings Yield	1.68%	2.33%	1.79%	2.81%	-	-
FCF Yield	-1.03%	-0.48%	0.19%	1.82%	-	-
Dividend Yield	1.27%	1.85%	1.04%	3.81%	-	-
Payout Ratio	76.01%	78.18%	209.31%	151.70%	-	167.01%
Buyback Yield / Dilution	-0.19%	-0.30%	-5.70%	-25.24%	-0.46%	0.23%
Total Shareholder Return	1.08%	1.55%	-4.66%	-21.43%	-0.46%	0.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.